Apeloa PharmaceuticalLtd Management
Management criteria checks 4/4
Apeloa PharmaceuticalLtd's CEO is Chun He, appointed in Jan 2024, has a tenure of less than a year. directly owns 0.004% of the company’s shares, worth CN¥696.69K. The average tenure of the management team and the board of directors is 11.8 years and 5.8 years respectively.
Key information
Chun He
Chief executive officer
CN¥903.6k
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | less than a year |
| CEO ownership | 0.004% |
| Management average tenure | 11.8yrs |
| Board average tenure | 5.8yrs |
Recent management updates
Recent updates
Apeloa Pharmaceutical Co.,Ltd (SZSE:000739) Looks Inexpensive But Perhaps Not Attractive Enough
Nov 09
Apeloa PharmaceuticalLtd (SZSE:000739) Seems To Use Debt Quite Sensibly
Sep 30Lacklustre Performance Is Driving Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Low P/E
Aug 07Is Apeloa PharmaceuticalLtd (SZSE:000739) Using Too Much Debt?
Jun 24Apeloa Pharmaceutical Co.,Ltd's (SZSE:000739) Share Price Boosted 26% But Its Business Prospects Need A Lift Too
May 08CEO
Chun He (50 yo)
less than a year
Tenure
CN¥903,600
Compensation
Mr. Chun He is General Manager of Apeloa Pharmaceutical Co. Ltd. since 2024 and served as its Senior Deputy General Manager until 2024 and served as its GM of Formulation Division since June 2022 until 202...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 11.8yrs | CN¥2.40m | 0.019% CN¥ 3.6m | |
| General Manager | less than a year | CN¥903.60k | 0.0038% CN¥ 710.7k | |
| Vice Chairman | less than a year | CN¥1.44m | 0.0095% CN¥ 1.8m | |
| Chief Financial Officer | 5.9yrs | CN¥653.60k | 0.00038% CN¥ 71.4k | |
| Senior Deputy GM & GM of API Division | no data | CN¥903.60k | 0.0043% CN¥ 812.2k | |
| Deputy GM & GM of CDMO Division | no data | CN¥810.00k | 0.0043% CN¥ 812.2k | |
| Deputy GM & Secretary | no data | CN¥633.60k | no data | |
| Chief Technology Officer | 13.6yrs | CN¥360.00k | no data |
11.8yrs
Average Tenure
52yo
Average Age
Experienced Management: 000739's management team is seasoned and experienced (11.8 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chairman | 11.8yrs | CN¥2.40m | 0.019% CN¥ 3.6m | |
| Vice Chairman | less than a year | CN¥1.44m | 0.0095% CN¥ 1.8m | |
| Non-Independent Director | 11.8yrs | CN¥2.80m | 0.0086% CN¥ 1.6m | |
| Non-Independent Director | 23yrs | no data | no data | |
| Non-Independent Director | 16.6yrs | no data | no data | |
| Supervisor | 1.7yrs | no data | no data | |
| Chairman of the Supervisory Board | 7yrs | no data | no data | |
| Independent Director | 4.7yrs | CN¥88.20k | no data | |
| Independent Director | 3.7yrs | CN¥88.20k | no data | |
| Independent Director | 2.8yrs | CN¥88.20k | no data |
5.8yrs
Average Tenure
54.5yo
Average Age
Experienced Board: 000739's board of directors are considered experienced (5.8 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 17:07 |
| End of Day Share Price | 2024/12/26 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Apeloa Pharmaceutical Co.,Ltd is covered by 13 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Jin Zhang | China International Capital Corporation Limited |
| Wanhua Wu | China International Capital Corporation Limited |
| Shanshan Li | China Merchants Securities Co. Ltd. |